FabriXense

Israel

FabriXenseis developing a new wearable, continuous and contactless smart cloth for monitoring the mother-to-be and her fetus for having a healthy pregnancy period. FabriXense incorporates biometric monitoring into smart clothing to provide active and continuous measurement of biomedical parameters including heart rhythm, breathing, oximetry, and blood pressure. Its sensor technology is based on patented methods for measuring the reflection of light-penetrable optical fibers. The fiber-like sensors can be as thin as a few dozen microns, similar to the fibers used for optical communication. Special artifacts inserted into the fiber core use a two-stage detection process. The first stage involves the interaction of light with the wearer, as a portion of the light passes through the fiber and is reflected from the wearer's body back into the fiber. The second stage is interpretation by the in-fiber interferometer, which measures with high precision both movements and deformations in the fiber. FabriXense's fiber-based sensor is integrated into the clothing, and full contact with the wearer's skin is not required to perform the measurements. The sensor is suitable for all types of clothing.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out FabriXense on @MedStartr Today #MaternalHealth #Pregnancy #MaternalAndInfantHealth #Wearables #MedMo #MedStartrVentures

https://www.medstartr.ai/s/HY84tuQhpW4

Get Involved in FabriXense

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2015
Website: www.fabrixense.com

Disease Areas

Maternal Health Pregnancy Maternal and Infant Health

Technologies

Wearable DevicesSmart ClothingBiometric MonitoringRemote Monitoring

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of FabriXense?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.